CAR T Explained by Precision BioSciences

What do frozen samurai warriors and magic goggles have to do with treating cancer? Join Derek Jantz, Chief Science Officer at Precision BioSciences, on a journey into the future of cancer therapies, and learn how ARCUS-Precision's new genome editing technology-is used to make off-the-shelf, donor-derived CAR T cell therapies with the potential to change the way the world battles cancer.